TSANZ SIG Orals: Orphan Lung Diseases, Lung Transplant, Interstitial Lung Disease and Pulmonary Vascular Disease (OLIV) 1
Tracks
TSANZ Orals
Saturday, March 22, 2025 |
11:00 AM - 12:30 PM |
E2 |
Speaker
Miss Jennie Charoenphannathon
PhD Student
Monash University
Evaluation of the anti-fibrotic effects of bone marrow mesenchymal stem cell-derived extracellular vesicles in IPF patient-derived fibroblasts and bleomycin-injured mice
11:00 AM - 11:15 AMBiography
Jennie is a third year PhD student in the Department of Pharmacology at Monash University. Her research focuses on developing novel peptide and stem cell-associated therapies for idiopathic pulmonary fibrosis.
Prof Anne Holland
Head Of Respiratory Research
Monash University / Alfred Health
Ambulatory oxygen for treatment of exertional hypoxaemia in pulmonary fibrosis (PFOX trial): a randomised sham-controlled trial.
11:15 AM - 11:30 AMBiography
Anne Holland is Professor of Physiotherapy and Head of Respiratory Research at Monash University in Melbourne, Australia. She leads a research program that aims to improve the lives of people with chronic lung disease using novel non-pharmacological treatments. Anne is an NHMRC Leadership Fellow.
Doris Lan
PhD Student
University of Sydney
Impact of long-term low-level air pollution exposure on mortality and disease progression in interstitial lung disease patients
11:30 AM - 11:45 AMBiography
Doris Lan is a clinical trial nurse in interstitial lung diseases at Royal Prince Alfred Hospital, began her PhD in 2023 at the University of Sydney. Her research focuses on the geographical impact on ILD patients, aiming to inform policy changes for better accessibility and improved quality of life.
Dr Wenying Lu
Research Fellow
University of Tasmania
Patients with idiopathic pulmonary fibrosis have fatty lungs: implications for respiratory physiology
11:45 AM - 12:00 PMBiography
Dr Lu is a Research Fellow at the Respiratory Translational Research Group at the University of Tasmania. Since 2017, she has been conducting fundamental/clinical translational research on smoking-related chronic respiratory diseases, including COPD, lung cancer, and IPF. She is enthusiastic about understanding the pathogenesis of chronic respiratory diseases.
Dr Behdad Shaarbaf Ebrahimi
Research Fellow
University of Auckland
Predicting Pulmonary Hemodynamics and Vascular resistance in CTEPH Patients Using Pre- and Post-Surgical CTPA Data
12:00 PM - 12:15 PMBiography
Behdad is a research fellow at Auckland Bioengineering Institute (ABI) in the lung and respiratory group. Behdad received his PhD in bioengineering in 2022 on developing computational models for lung perfusion evaluating the impact of vascular remodelling in pulmonary hypertension.
Dr Oliver Armstrong-Scott
Respiratory Registrar
Te Whatu Ora Health Te Toka Tumai
Outcomes of lung transplantation post pleurodesis: the New Zealand experience
12:15 PM - 12:30 PMBiography
Oliver is a second year respiratory advanced trainee in the Auckland region of Aotearoa New Zealand. His research interests are in lung transplant and pulmonary vascular disease. He is the trainee representative on the executive committee of the TSANZ New Zealand branch.
Dr Megan Harrison
Consultant Respiratory Physician
Sir Charles Gairdner Hospital
Chairperson
Biography
Megan is an NHMRC postgraduate scholar undertaking a PhD looking at the utilisation of a treatable traits model of care in ILD through the University of Sydney. She works as a respiratory specialist in Western Australia.
Prof Edmund Lau
Senior Staff Specialist
Royal Prince Alfred Hospital
Chairperson
Biography
Edmund Lau is an academic respiratory physician working at Royal Prince Alfred Hospital, Sydney and Clinical Professor of Medicine at the University of Sydney. He is the lead Respiratory Physician of the Pulmonary Hypertension Service at Royal Prince Alfred Hospital. He is the Co-Director of the Australian and New Zealand Pulmonary Hypertension Registry. He has authored more than 120 peer-reviewed publications, mostly on the topic of pulmonary hypertension.
